| INTRODUCTION
General paresis (GP) was previously thought to be an uncommon cause of dementia (Rao, Ariba, Kanwardeep, Anderson, & Malone, 2015) . However, as the incidence of syphilis increased rapidly in the recent years, increasing numbers of GP patients were reported worldwide, and increasing attention has been paid to this disease (Moulton & Koychev, 2015; Wang et al., 2016; Zheng, Zhou, et al., 2011) . The GP is a clinical type of neurosyphilis (NS) resulting from invasion of the central nervous system by Treponema pallidum (Ghanem, 2010) . The clinical manifestations of GP are characterized by various psychiatric symptoms and progressive cognitive declines Costiniuk & MacPherson, 2013; Jantzen et al., 2012; Rao et al., 2015; Wang et al., 2011; Wang et al., 2016; Zheng, Webster, et al., 2011) . After treatment with penicillin, a resolution of clinical abnormalities has been found among both NS patients and GP patients (Hahn et al., 1959; Moulton & Koychev, 2015; Wilner & Brody, 1968) . However, previous studies have suggested that the effects of penicillin therapy on clinical outcomes vary among patients with GP and that recrudescence and deterioration should be considered (Hahn et al., 1959; Kodama et al., 2000; Wilner & Brody, 1968) .
If the clinical outcomes of GP patients can be predicted before treatment, early interventions may be carried out to prevent recrudescence and deterioration. Therefore, identifying the possible predictors of clinical outcomes in GP patients may not only offer a great deal of prognostic information before treatment but also pro- (Marra, Maxwell, Tantalo, Sahi, & Lukehart, 2008) , whereas change in Venereal Disease Research Laboratory (VDRL) titers may correlate with improvement in cognitive function in NS patients after treatment with penicillin (Roberts & Emsley, 1995) . However, whether laboratory results can serve as predictors of clinical outcomes in GP patients remains unclear.
Neuroimaging abnormalities may serve as more reliable predictors than laboratory results in GP patients, because false negative and false positive are inevitable in laboratory assessments of syphilis (Larsen, Steiner, & Rudolph, 1995) . Cerebral atrophy and white matter hyperintensities (WMH) are common in GP patients Picq, Aujard, Volk, & Dhenain, 2010; Wang et al., 2011; Zheng, Webster, et al., 2011) , and increasing evidence suggests that they may be correlated with the clinical abnormalities and clinical prognoses in GP patients. Wang et al. (2011) demonstrated 12 patients with mild GP who experienced overall cognitive declines and medial temporal lobe atrophy (MTA), but the researchers did not analyzed the correlations between cognitive function and MTA. Russouw, Roberts, Emsley, and Truter (1997) have demonstrated a significant association between frontal lesions and psychiatric symptoms, and a near-significant correlation between temporo-parietal lesions and cognitive impairment in NS patients, but whether these correlations exist in GP patients remains unclear. Kodama et al. (2000) have reported 4 GP patients with normal magnetic resonance imaging (MRI) or slight cerebral atrophy, who achieved significant improvement in clinical symptoms and social functioning after treatment, whereas poor outcomes have been found in 3 GP patients with MTA, thus suggesting that MTA may be a poor prognostic factor for GP. However, given the small sample sizes and the absence of objective clinical and neuroimaging assessments, their conclusions should be interpreted with caution.
To explore factors that might serve as predictors of clinical outcomes in GP patients, we performed comprehensive neuropsychological assessments, neuroimaging examinations and laboratory tests in GP patients before and after penicillin therapy. Because the clinical manifestations of GP are characterized by progressive cognitive decline and various psychiatric symptoms, the relevant neuropsychological assessments were used to quantify the clinical characteristics and outcomes in GP patients. Although multimodal MRI analysis is currently popular, its complicated algorithms, high cost and timeconsuming procedure may not be acceptable for many clinicians and patients. Therefore, the severities of neuroimaging abnormalities in GP were qualitatively assessed by using relevant rating scales in our study, because we prefer classical and clinical MRI analysis, which are more practical and applicable in clinical use. 
| Procedures
Each GP patient underwent a standard clinical evaluation, including history, physical assessment neurological examinations, neuroimaging and laboratory measurements. After a diagnose of GP was confirmed, the patient underwent comprehensive neuropsychological assessments, and penicillin was administered according to the US CDC guideline (Workowski K A, & Berman S., 2010) . The details were as follows: aqueous crystalline penicillin G at 24 million units per day was administered in a continuous infusion for 14 days, then benzathine penicillin at 2.4 million units intramuscular injections (IM) was administered once per week for 3 weeks. Patients returned for follow-up visits after 6 months. Follow-up evaluations included neuropsychological assessments, neuroimaging and laboratory examinations. The dose of penicillin was standardized in each GP patient, and no antipsychotics or cognitive enhancers were used by any of the GP patients in this study.
| Neuropsychological assessments
The severity of dementia was determined on the basis of Clinical Dementia Rating Scale (CDR) (Hughes, Berg, Danziger, Coben, & Martin, 1982) . Cognitive function was assessed on the basis of the Mini Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975 )and Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog). The Chinese version of ADAS-cog consists of 12 items and measures 4 cognitive domains: memory, language, praxis and attention (Mohs, Rosen, & Davis, 1983; Wang et al., 2004) . The ability of daily living were assessed by Instrumental Activities of Daily Living Scale (IALD) and Physical Self maintenance Scale (PSMS) (Lawton & Brody, 1969) . The Chinese version of neuropsychiatric inventory (NPI) was used to assess behavioural and psychological symptoms, and the NPI total scores were calculated as the sum of the 12 items in the NPI as frequency × severity (Cummings et al., 1994; Leung, Lam, Chiu, Cummings, & Chen, 2001 ).
All neuropsychological assessments were performed by 2 professional raters, and the intraclass correlation coefficients (ICCs) ranged from 0.947 to 0.993, thus indicating good interobserver reliability.
| Neuroimaging evaluations
Brain magnetic resonance imaging (MRI) scans were performed before penicillin was administered, using a Philips 3.0T Achieva system (Philips, Best, The Netherlands) located at Guangzhou Huiai Hospital. The visual rating of medial temporal lobe was used to assess the severity of MTA (Scheltens, Leys, Barkhof, et al., 1992) , and the Fazekas scale was used to assess the severity of WMH (Fazekas, Chawluk, Alavi, Hurtig, & Zimmerman, 1987) . All evaluations were performed by 2 radiologists who were blinded to patients' conditions, and the ICCs for them were 0.922 (MTA) and 0.908 (Fazekas scale).
| Laboratory measurements
The CSF samples of GP patients were collected in the morning through lumbar puncture, and blood samples were collected within 1 hour after lumbar puncture. All samples were collected before penicillin therapy was administered. The laboratory results were measured in hospital clinical laboratories.
| Statistics
Normally distributed data were presented as mean AE SD, non-normally distributed data were presented as medians (interquartile range 3 | RESULTS
| Demographic and neuropsychological
The demographic characteristics of GP are as below: 33 male and 2 female, ages 53.6 AE 7.9, year of education 9.7 AE 2.7. The disease course of GP patients was 1.0 (1.0, 3.0) years, and the duration of follow-up is 7.4 AE 1.6 months. The neuropsychological test scores of GP patients before and after treatment are listed in Table 1 . All patients completed all neuropsychological tests before and after treatment, except for 3 patients who failed to complete the ADASCog because of their poor cognitive function. Table 2 . Small reductions of WMH area and more cerebral atrophy were observed in GP patients after treatment, but no GP patient had changes in MTA or Fazekas scale scores (Figure 1 ).
| Neuroimaging

| Laboratory
The laboratory results of GP patients were listed in Tables 1 and   Tables 3 . The change in serum RPR titers and CSF protein level in different GP groups, as grouped by CDR and MTA scores, are listed in Table 4 . Change in neuropsychological test scores in GP patients with/without normalization of serum RPR is listed in Table 5 . No correlations were found among any laboratory results and neuropsychological test scores (P > .05).
| Possible predictors of clinical outcomes
The pre-treatment MTA scores significantly correlated with change in Table 4 .
| DISCUSSION
This is the first follow-up study to include the neuropsychological, laboratory and neuroimaging results of GP patients before and after penicillin therapy, as well as qualitative analysis of the neuroimaging abnormalities of GP on the basis of visual rating scales. Our study revealed 3 major results. First, we statistically quantified the clinical manifestations of GP and confirmed that mild GP resulted in better cognitive outcomes than severe GP. Second, we found that severe MTA before treatment correlated with severe cognitive impairment and poor cognitive outcomes in GP patients, while WMH was associated with the attention impairment, thus suggesting that the classical MRI analysis (visual rating scales) provides useful biomarkers in GP. Finally, our results showed that the normalization of serum RPR titers indicated a significant improvement of cognitive function and psychotic symptoms in GP.
We found that GP patients experienced overall declines in cognitive function, including memory, language, praxis and attention, in agreement with results from previous studies (Wang et al., 2011) .
Recent studies have reported an Alzheimer's disease (AD)-like pattern in GP patients, such as an overall decline in cognitive functions (Wang et al., 2011) , MTA (Kodama et al., 2000) , lower CSF Ab42 levels (Luo et al., 2015) and lower CSF CysC levels (Zhong et al., 2013) . However, in NS, unlike AD, the cognitive impairment caused by T. pallidum is considered to be "reversible dementia" because improvements in cognitive function have been found in NS patients after treatment with penicillin (Moulton & Koychev, 2015) . However, as Moulton's system review has indicated, the overall quality of previous studies on the effect of penicillin therapy on cognitive outcomes in NS was relatively poor, because of the lack of objective and systematic neuropsychological examinations, inappropriate length of follow-up, small sample sizes and large amounts of missing data (Moulton & Koychev, 2015) . Moreover, the conclusions for NS may not be suitable for GP because NS includes different clinical types (GP, asymptomatic NS, syphilitic meningitis, meningovascular syphilis and tabes dorsalis) (Ghanem, 2010) . Through quantitative analysis, we confirmed the significant improvements in cognitive function in GP patients and found that mild GP patients tended to have better cognitive outcomes than severe GP patients. These results emphasize the importance of early diagnosis and treatment in GP patients.
Neuroimaging abnormalities were common (97.1%) in GP patients in our study. Cerebral atrophy , the most frequent manifestation of GP, has been correlated with the destruction of the cerebral cortex, loss of neurons and cognitive impairment Picq et al., 2010; Wang et al., 2011; Zheng, Webster, et al., 2011) .
The medial temporal lobe may play important role in GP, because an increasing number of case reports indicates that MTA may be a prominent feature and a poor prognostic sign in GP Kodama et al., 2000; Van, Veldink, Linn, Scheltens, & Biessels, 2008; Wang et al., 2011) . The reason why atrophy occurs in the medial temporal lobe remains unclear. It may happen secondarily to dysfunction in the diffuse cerebral cortex because the medial temporal lobe is closely connected to the cerebral association areas, which included the temporal, parietal and frontal lobes (Kodama et al., 2000) . In our study, 85.3% of GP patients suffered from MTA, and 44.1% of them had MTA scores of 2. The MTA scores significantly correlated with CDR-SB, the MMSE scores, and the total scores and memory scores of ADAS-Cog in GP patients, thus suggesting that GP patients with more severe MTA tended to have poorer cognitive function, especially poorer memory. Furthermore, there is no GP patient who had changes in MTA scores in follow-up evaluation, possibly resulting in their incomplete improvement of cognitive function after treatment. Additionally, the pre-treatment MTA scores were negatively associated with change in MMSE scores, and there were no significant improvement in cognitive test scores in GP patients with MTA scores >2, thus suggesting that severe MTA correlated with poor cognitive outcomes in GP. These results are consistent with what we described above: mild GP patients have better cognitive outcomes than do severe GP patients. These results suggest that MTA may serve as not only an indicator of severe cognitive impairment, but also a predictor of poor cognitive outcome in GP. The medial temporal lobe plays an important role in the cognitive map, and MTA has been considered to be a prominent feature of AD (Jack et al., 2000) . In mild cognitive impairment patients, poorer general cognition and hippocampal atrophy can predict subsequent accelerated rates of hippocampal atrophy and poor cognitive outcomes, Group by CDR scores Group by MTA scores CDR = 0.5 (n = 10) CDR = 1 (n = 12) CDR > 1 (n = 13) MTA < 2 (n = 9) MTA = 2 (n = 15) MTA > 2 (n = 10) 1 Mean AE SD of "Ln(1/X) -Ln(1/Y)," "X" means serum RPR titers before treatment, "Y" means serum RPR titers after treatment. which are suggestive of the accumulation of AD-type pathology (Jack et al., 2000) . Our results provide new evidence that supports the ADlike pattern in GP. Because the follow-up evaluation was approximately 7 months in our study, further study with a longer follow-up period are needed to observe the change in MTA. Overall, neuroimaging assessments were of great significant in GP patients, and the MTA scales offer clinicians an efficient way to evaluat their GP patients. More attention should be paid to GP patients with severe MTA, and effective interventions for improving their cognitive function may be considered.
Additionally, 74.3% of the GP patients had WMH, and 65.7% of them had Fazekas scale scores of 1 in our study. The WMH of GP patients may result from a reduction of cerebral blood flow, inflammation, cytotoxicity, interstitial, edema components, microglial hypertrophy, and meningovasculitis (Gürses et al., 2007; Kodama et al., 2000; Xiang et al., 2013) . It has been suggested that the WMH volume in the frontal lobe regions correlated with processing speed and performance on measures of attention in older stroke patients (Burton et al., 2004) , but whether WMH is associated with cognitive impairment in GP patients is not clear. Our results suggested that GP patients with WMH tended to have poorer attention function. Interestingly, attention was the only cognitive domain in GP that improved significantly after penicillin therapy in our study. Attention function relies on complicated interaction of multiple brain regions, such as temporal-parietal junction, parietal cortex, prefrontal cortex and anterior cingulate (Posner & Rothbart, 2006) . Notably, we found that In our study, although laboratory results were not associated with any pre-treatment neuropsychological test scores or change in neuropsychological test scores in GP patients, the dynamic changes in serum RPR titers may serve as sensitive indicators of therapeutic effect in GP. First, the serum RPR titers decreased significantly in mild GP compared with severe GP. As mentioned above, significant improvements in cognitive function were also found in mild GP rather than severe GP, thus suggesting that the change in serum RPR titers may parallel the change in cognitive function in GP. Second, significant improvements in cognitive test scores were found in GP patients with normalization of serum RPR titers, but not in those without serum RPR titers. A previous study has indicated that the normalization of serum RPR titers is predictive of a normalization of CSF and clinical abnormalities after treatment in NS patients (Marra et al., 2008) .In quantitative and comprehensive neuropsychological assessments, we confirmed that for GP patients, the normalization of serum RPR titers after penicillin therapy also associated with significant improvements in cognitive function and activities of daily living, and the remission of psychiatric symptoms. In contrast, we found that TPHA, CSF WBC count and CSF protein level were not sensitive indicator of therapeutic effect in GP, results consistent with findings from a previous study on NS (Marra et al., 2008) .
Various psychotic symptoms were found in GP patients in our study, which was consisted with previous studies (Wang et al., 2011; Zheng, Webster, et al., 2011) . After penicillin therapy, remission was found in most of the psychotic symptoms in GP patients, whereas apathy was the only psychotic symptom that was aggravated. This result underscores that more intervention should be carried out to address apathy in GP patients. In our study, there was no correlation between psychotic symptoms and neuroimaging or laboratory results, and the changing patterns of cognitive function and psychotic symptom of GP were markedly different, that GP patients with severe dementia and severe MTA still achieved significant improvement in NPI scores. Previous studies have indicated that frontal lobe lesions may associate with psychiatric symptoms (Russouw et al., 1997) .
Thus, further studies with effective instrument for analyzing frontal lobe lesions are needed to explore the correlation among psychiatric symptoms and neuroimaging abnormalities.
| CONCLUSION
Severe MTA may serve as a predictor of poor cognitive outcomes and an indicator of overall cognitive impairment in GP patients, and early interventions for improving cognitive function may be considered for GP patients with severe MTA. The WMH may associate with attention impairment. The normalization of serum RPR titers may suggest a significant improvement in clinical abnormalities in GP patients.
| Limitation
First, we analyzed the clinical outcomes of GP patients within 1 year, and the sample size is relatively small, which hindered us to divide GP patients into 5 groups (MTA scores range from 0 to 4) and analyze them, respectively. Further studies with larger sample sizes and a longer follow-up period are needed to explore the long-term outcome in GP. Second, we analyzed neuroimaging data qualitatively to offer clinicians more practical information; further quantitative studies with multimodal MRI analyses are needed to validate these correlations between neuroimaging characteristics and clinical manifestations of GP patients. Finally, not all GP patients received the laboratory tests and neuroimaging assessments, thus resulting in missing data in our study.
